University at Buffalo - The State University of New York
Skip to Content

Home-Brewed Drugs and the Drug Development Process

Date:
Tuesday, September 5, 2017
Time:
4:00 pm - 5:00 pm
Location:
Zebro Conference Room, Roswell Park Cancer Institute
Presenter:
Lyudmila Burdelya, PhD, and Vadim Krivokrysenko, PhD
Sponsor:
UB Clinical and Translational Science Institute

Lyudmila Burdelya, PhD, and Vadim Krivokrysenko, PhD, "Entolimod as a dual use oncology biodefense drug"
Organized by the UB Clinical and Translational Science Institute Drug Development Core, this series presents:
- Case studies in drug discovery and pre-clinical development
- Opportunities to become familiar with GLP and pre-clinical drug development programs
- Regulatory compliance leading to IND application
- Strategies for translation to Phase I study design

Links

For more information, contact:

Kelly Patton, MSHA
Email: kepatton@buffalo.edu